Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Synergistic Induction of UCP-1 by Ephedrine/Caffeine and Pioglitazone: A Rationale for Combination Therapy of Obesity

NCT00377975 is registered in ClinicalTrials.gov with Pennington Biomedical Research Center as lead sponsor.

NCT NCT00377975
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00377975 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Synergistic Induction of UCP-1 by Ephedrine/Caffeine and Pioglitazone: A Rationale for Combination Therapy of Obesity
Lead sponsor
Pennington Biomedical Research Center
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2003
Completion date
November 30, 2004
Enrollment
96
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity